Enzyme immunoassay for the specific and quantitative determination of free Certolizumab Pegol (Cimzia®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Certolizumab Pegol. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Reference: IG-AB109
Barcode: 8682754930257
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Cimzia® is a trademark of UCB.
